Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision
James R. Wright(Duke University), Mark N. Levine(Juravinski Cancer Centre), Amiram Gafni(The Centre for Health (New Zealand)), Timothy J. Whelan(Juravinski Cancer Centre), Dauna Crooks(American Society of Clinical Oncology), Kathleen I. Pritchard, Sacha Dubois(Lakehead University), Susan Schiff(American Society of Clinical Oncology), Robin S. Roberts(Impact), Patricia Haines(American Society of Clinical Oncology), Diane DeRosa(American Society of Clinical Oncology)
Cited by 138
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
The Zarit Burden Interview
|The Gerontologist|2001|1.7k
Canadian Implantable Defibrillator Study (CIDS)
|Circulation|2000|1.6k
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
|New England Journal of Medicine|2004|1.5k
Regional Nodal Irradiation in Early-Stage Breast Cancer
|New England Journal of Medicine|2015|1.3k